E-LIB Suche - Ergebnisse für: Vormoor, Britta

1

Fludarabine Exposure Predicts Outcome after CD19 CAR T Cell..:

Dekker, Linde ; Calkoen, Friso ; Jiang, Yilin...
Transplantation and Cellular Therapy. 28 (2022) 3 - p. S104-S105 , 2022

Link: https://doi.org/10.1016/..

2

Inotuzumab ozogamicin as single agent in pediatric patients..:

Pennesi, Edoardo ; Michels, Naomi ; Brivio, Erica...
Leukemia. 36 (2022) 6 - p. 1516-1524 , 2022

Link: https://doi.org/10.1038/..

3

Targeted inhibitors and antibody immunotherapies: Novel the..:

Brivio, Erica ; Baruchel, André ; Beishuizen, Auke...
European Journal of Cancer. 164 (2022) - p. 1-17 , 2022

Link: https://doi.org/10.1016/..

4

Outcome of chimeric antigen receptor T-cell therapy followi..:

Ceolin, Valeria ; Brivio, Erica ; van Tinteren, Harm...
Leukemia. 37 (2022) 1 - p. 53-60 , 2022

Link: https://doi.org/10.1038/..

5

Fludarabine exposure predicts outcome after CD19 CAR T-cell..:

Dekker, Linde ; Calkoen, Friso G. ; Jiang, Yilin...
Blood Advances. 6 (2022) 7 - p. 1969-1976 , 2022

Link: https://doi.org/10.1182/..

6

CD19 CAR T-cells for pediatric relapsed acute lymphoblastic..:

Jacoby, Elad ; Ghorashian, Sara ; Vormoor, Britta...
Leukemia. 36 (2022) 6 - p. 1525-1532 , 2022

Link: https://doi.org/10.1038/..

7

Selumetinib in combination with dexamethasone for the treat..:

Menne, Tobias ; Slade, Daniel ; Savage, Joshua...
BMJ Open. 12 (2022) 3 - p. e059872 , 2022

Link: https://doi.org/10.1136/..

8

Targeted inhibitors and antibody immunotherapies:Novel ther..:

Brivio, Erica ; Baruchel, André ; Beishuizen, Auke...
Brivio , E , Baruchel , A , Beishuizen , A , Bourquin , J P , Brown , P A , Cooper , T , Gore , L , Kolb , E A , Locatelli , F , Maude , S L , Mussai , F J , Vormoor-Bürger , B , Vormoor , J , von Stackelberg , A & Zwaan , C M 2022 , ' Targeted inhibitors and antibody immunotherapies : Novel therapies for paediatric leukaemia and lymphoma ' , European Journal of Cancer , vol. 164 , pp. 1-17 . https://doi.org/10.1016/j.ejca.2021.12.029. , 2022

Link: https://pure.eur.nl/en/p..

9

Selumetinib in combination with dexamethasone for the treat..:

Menne, Tobias ; Slade, Daniel ; Savage, Joshua...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900053/. , 2022

Link: http://www.ncbi.nlm.nih...

10

Inotuzumab ozogamicin as single agent in pediatric patients..:

Pennesi, Edoardo ; Michels, Naomi ; Brivio, Erica...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162924/. , 2022

Link: http://www.ncbi.nlm.nih...

11

Fludarabine exposure predicts outcome after CD19 CAR T-cell..:

Dekker, Linde ; Calkoen, Friso G ; Jiang, Yilin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006280/. , 2022

Link: http://www.ncbi.nlm.nih...

12

MAPK-ERK is a central pathway in T-cell acute lymphoblastic..:

van der Zwet, Jordy C. G. ; Buijs-Gladdines, Jessica G. C. A. M. ; Cordo', Valentina...
Leukemia. 35 (2021) 12 - p. 3394-3405 , 2021

Link: https://doi.org/10.1038/..

13

MAPK-ERK is a central pathway in T-cell acute lymphoblastic..:

van der Zwet, Jordy C.G ; Buijs-Gladdines, Jessica G.C.A.M ; Cordo', Valentina...
https://dspace.library.uu.nl/handle/1874/418895. , 2021

Link: https://dspace.library.u..

14

Sensitizing Ewing sarcoma to chemo- and radiotherapy by inh..:

Vormoor, Britta ; Schlosser, Yvonne T. ; Blair, Helen...
Oncotarget. 8 (2017) 69 - p. 113418-113430 , 2017

Link: https://doi.org/10.18632..

15

Development of a Preclinical Orthotopic Xenograft Model of ..:

Vormoor, Britta ; Knizia, Henrike K. ; Batey, Michael A....
PLoS ONE. 9 (2014) 1 - p. e85128 , 2014

Link: https://doi.org/10.1371/..